altRx vs Sprout Health: Pricing, Speed, and Availability
Quick verdict: altRx is focused on low starting price and predictable monthly pricing while Sprout Health prioritizes fast approval and an introductory discount. In an altRx vs Sprout Health comparison, altRx markets compounded semaglutide starting at $89/month and compounded tirzepatide at $149/month; Sprout Health advertises $50 off the first month, bringing that initial month to $199 with ongoing pricing at $249/month.
What differs most: price, onboarding speed, and medication type
The primary differences between altRx and Sprout Health are price structure, onboarding speed and approval framing, and how each frames outcomes and compounded medication status. Both providers operate fully online, use clinician review, and may prescribe compounded GLP-1 products when appropriate. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality; that regulatory note applies to both when they offer compounded products.
Price and billing: altRx emphasizes a low starting price
altRx positions itself as the most affordable GLP-1 program with a limited offer: compounded semaglutide at $89/month and compounded tirzepatide at $149/month. altRx also lists multi-month pricing reductions for semaglutide and tirzepatide on 3, 6, and 12 month plans. altRx states there are no membership, insurance or hidden fees, and that plans can be canceled anytime. Sprout Health highlights a $50 off the first month promotion, bringing that first month to $199, with ongoing pricing at $249/month according to the captured evidence.
Get Sprout Health $50 off first month
Onboarding and approval speed
Sprout Health emphasizes a lightning-quick approval process and a fast, low-friction entry to GLP-1 therapy. That quick approval framing is a core part of Sprout Health’s positioning. altRx also offers 100% online medical visits and a two-minute quiz to get started, but its messaging centers on affordability rather than fastest possible approvals.
Medication type and regulatory notes
Both providers offer compounded GLP-1 medication options in evidence captured here. The source for altRx explicitly notes prescriptions are filled by state-licensed 503A compounding pharmacies in its network and that compounded medications are not FDA-approved. Sprout Health’s evidence also states that compounded medications, when offered, are not FDA-approved. Neither provider is described here as offering branded FDA-approved finished products in the captured evidence.
Service features and support
altRx lists features including free and discreet 2-day delivery, 100% online medical visits, buy now pay later options through Affirm, Klarna, and Afterpay, and ongoing care team support. altRx also promotes an all-inclusive monthly fee covering medical oversight, medication, and support. Sprout Health emphasizes fast delivery after rapid approval and frames outcomes as 10 to 26 percent body weight reduction over 12 months in its marketing, while also presenting a simple, fast-entry experience.
Comparison table: altRx vs Sprout Health
| Criteria | altRx | Sprout Health |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Tirzepatide $149/mo | $50 off first month to $199; $249/mo ongoing |
| Onboarding speed | 100% online visits; 2-minute quiz to start | Lightning-quick approval process |
| Medication type | Compounded GLP-1 products via 503A pharmacies | Compounded GLP-1 products when offered |
| Delivery | Free, discreet 2-day delivery stated | Home delivery after approval; timing not captured |
| Cancellation / commitment | No commitment; cancel anytime | Not specified in captured evidence |
How each provider frames outcomes and target patients
Sprout Health explicitly frames outcomes as 10 to 26 percent body weight reduction over 12 months in its marketing materials and targets patients who want fast entry and clear outcome framing. altRx is aimed at patients who have been held back by price and emphasizes being the most affordable GLP-1 program, with an offer starting at $89/month for compounded semaglutide and $149/month for compounded tirzepatide.
Safety and clinician oversight
Both providers state that a licensed clinician reviews intake and determines whether treatment is medically appropriate. altRx notes that a licensed provider will review a health evaluation and conduct a telehealth consultation, and that prescriptions are sent to a licensed pharmacy if appropriate. Sprout Health also requires clinician determination for treatment and emphasizes rapid review. The regulatory note that compounded medications are not FDA-approved applies to both when compounded products are used.
Conclusion: altRx vs Sprout Health — which to choose
In an altRx vs Sprout Health comparison, choose altRx if your priority is the lowest advertised starting price, predictable same price every month messaging, free 2-day delivery, and multi-month discounts. Choose Sprout Health if your priority is lightning-quick approval and an introductory $50 off the first month that reduces the initial month to $199 with ongoing pricing at $249/month.